Diverse inflammatory diseases, infections and malignancies are associated with wasting
syndromes. In many of these conditions, the standards for diagnosis and treatment are …

Systemic inflammation is a marker of poor prognosis preoperatively present in around 20%-
40% of colorectal cancer patients. The hallmarks of systemic inflammation include an …

Cancer cachexia (CC) is a multifactorial syndrome in patients with advanced cancer
characterized by weight loss via skeletal-muscle and adipose-tissue atrophy, catabolic …

Colorectal cancer (CRC) is one of the most common cancers worldwide, which ranks third in
terms of incidence and the second leading cause of cancer-related mortality. Metabolic …

SARS-CoV-2 vaccinations have greatly reduced COVID-19 cases, but we must continue to
develop our understanding of the nature of the disease and its effects on human immunity …

Background Systemic immune inflammation is a key mediator in the progression of coronary
artery disease (CAD), concerning various metabolic and lipid changes. In this study, the …

Background A significant proportion of colorectal cancer (CRC) patients suffer from early
recurrence and progression after surgical treatment. Although the gut microbiota is …

Background Amino acid metabolism is dysregulated in colorectal cancer patients; however,
it is not clear whether pre-diagnostic levels of amino acids are associated with subsequent …

Early and accurate detection of colorectal cancer (CRC) is critical for improving patient
outcomes. Existing diagnostic techniques are often invasive and carry risks of complications …

Dietary patterns contribute to cancer risk. Separately, microbial factors influence the
development of several cancers. However, the interaction of diet and the microbiome and …